We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · February 10, 2021

Systematic TRUS Biopsy vs mMRI–Targeted Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer

JAMA Oncology


Additional Info

JAMA Oncology
Comparison of Multiparametric Magnetic Resonance Imaging–Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial
JAMA Oncol 2021 Feb 04;[EPub Ahead of Print], L Klotz, J Chin, PC Black, A Finelli, M Anidjar, F Bladou, A Machado, M Levental, S Ghai, S Chang, L Milot, C Patel, Z Kassam, C Moore, V Kasivisanathan, A Loblaw, M Kebabdjian, CC Earle, GR Pond, MA Haider

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.

Further Reading